AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study
- Posted on September 1, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study
Sept 1 (Reuters) - AstraZeneca and China's Hutchmed said on Tuesday that a late-stage trial of a combination of their cancer drugs Tagrisso and Orpathys significantly improved progression-free survival when given early for a type of lung cancer. Cancer therapies make up nearly half of AstraZeneca's sales and Tagrisso is one of its best-selling drugs, while Orpathys is being developed along with
